Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard L Parnes

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.
Cancers|November 27, 2021
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant DiseaseAndrew Bakshi, Moeen Riaz, Suzanne G Orchard, et al.
BJU International|May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillanceJonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkersEmmanuel S Antonarakis, Elisabeth I Heath, Janet R Walczak, et al.
European Urology Oncology|April 19, 2021
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active SurveillanceLuke P O'Connor, Alex Z Wang, Nitin K Yerram, et al.
The Journal of Urology|March 11, 2021
Reply by AuthorsNitin K Yerram, Lori Long, Luke P O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancerYang-Min Ning, James L Gulley, Philip M Arlen, et al.
The Prostate|August 14, 2012
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancerAmit M Algotar, M Suzanne Stratton, Frederick R Ahmann, et al.
JAMA Oncology|February 23, 2018
A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk StratificationSherif Mehralivand, Joanna H Shih, Soroush Rais-Bahrami, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.
Cancers|November 27, 2021
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant DiseaseAndrew Bakshi, Moeen Riaz, Suzanne G Orchard, et al.
BJU International|May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillanceJonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkersEmmanuel S Antonarakis, Elisabeth I Heath, Janet R Walczak, et al.
European Urology Oncology|April 19, 2021
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active SurveillanceLuke P O'Connor, Alex Z Wang, Nitin K Yerram, et al.
The Journal of Urology|March 11, 2021
Reply by AuthorsNitin K Yerram, Lori Long, Luke P O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancerYang-Min Ning, James L Gulley, Philip M Arlen, et al.
The Prostate|August 14, 2012
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancerAmit M Algotar, M Suzanne Stratton, Frederick R Ahmann, et al.
JAMA Oncology|February 23, 2018
A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk StratificationSherif Mehralivand, Joanna H Shih, Soroush Rais-Bahrami, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Pageof 11